eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | autosomal dominant polycystic kidney disease |
| Comorbidity | C0023895|liver disease |
| Sentences | 6 |
| PubMedID- 25369108 | Results: we included 43 adpkd patients with polycystic liver disease (84% female, median age 50 years, mean egfr 63 ml/min/1.73 m(2) ). |
| PubMedID- 24987537 | Combined liver and kidney transplant in a patient with budd-chiari syndrome secondary to autosomal dominant polycystic kidney disease associated with polycystic liver disease: report of a case with a 9-year follow-up. |
| PubMedID- 23355918 | A review of literature on polycystic liver disease in patients with adpkd and current management strategies are presented. |
| PubMedID- 22475206 | adpkd patients with symptomatic polycystic liver disease gigot type ii (diffuse medium-size cysts; hepatic parenchyma preserved) or gigot type iii (massive, diffuse small- and medium-size cysts; little hepatic parenchyma preserved) between 18 and 70 years are eligible for participation of the study [18]. |
| PubMedID- 23499726 | Background & aims: polycystic liver disease (pld) is associated with autosomal dominant polycystic kidney disease (adpkd) or autosomal dominant polycystic liver disease (pcld). |
| PubMedID- 22773240 | Background: we showed in a randomized double-blinded placebo-controlled clinical trial that octreotide long-acting repeatable depot.(r) (octlar((r))) for 12 months reduces kidney and liver growth in autosomal dominant polycystic kidney patients with severe polycystic liver disease (pld) and liver growth in patients with severe isolated pld. |
Page: 1